by Stem Cell Network | Dec 29, 2010
Earlier this month, the Honourable Tony Clement, Minister of Industry, announced the establishment of the Centre for the Commercialization of Regenerative Medicine (CCRM) with a $15 million initial investment. The CCRM will be based in Toronto and is one of five new...
by Allison Van Winkle | Sep 23, 2010
The transplantation of stem cells for use in regenerative medicine, where diseased or degenerated tissue is replaced with a new cell source, is an exciting field of research. However, prior to the implementation of a cell therapy, large amounts of cells will be...
by Katie Moisse | Sep 17, 2010
Replacing dead or dying cells with new, healthy ones is the holy grail of regenerative medicine. Even sustaining damaged cells with toxin-mopping, growth-factor-spewing stem-cell-derived support cells would be a tremendous feat. But while clinical trials have hinted...
by Stem Cell Network | Aug 25, 2010
Right now, you’re seeing this blog post thanks to your cornea. In concert with your eye’s lens, the cornea refracts light and allows you to distinguish the letters on this page from the background. But your cornea is vulnerable to disease — clouding...
by Allison Van Winkle | Jun 30, 2010
In the body, cartilage has minimal potential to heal itself once damaged, as the tissue is not naturally exposed to a blood supply, and is then prevented from benefiting from the body’s immune response and wound healing capabilities. By using a tissue engineering...
Comments